8-K/AExhibits & Filings

TransDigm Group INC 8-K/A Report, Exhibit Filing (May 30, 2019)

Filed May 30, 2019For Securities:TDG

Summary

This 8-K/A filing from TransDigm Group (TDG) is an amendment primarily focused on providing updated financial information related to the acquisition of Esterline. It incorporates previously filed financial statements of Esterline and includes unaudited pro forma condensed consolidated financial statements for TransDigm and Esterline on a combined basis for the fiscal year ended September 30, 2018, and the quarterly period ended December 29, 2018. Investors should note that this filing provides the necessary financial disclosures to reflect the impact of the Esterline acquisition. The incorporation by reference of Esterline's historical financials and the inclusion of pro forma combined statements are crucial for understanding the combined entity's financial position and performance post-acquisition. The filing also includes the consent of Esterline's independent auditors.

Key Highlights

  • 1Filing is an amendment (8-K/A) providing financial statements and exhibits related to the Esterline acquisition.
  • 2Audited consolidated financial statements of Esterline as of September 28, 2018, and for the year then ended are incorporated by reference.
  • 3Esterline's quarterly report for the period ended December 28, 2018, is also incorporated by reference.
  • 4Unaudited pro forma condensed consolidated financial statements for the combined TransDigm and Esterline entity are filed for the year ended September 30, 2018.
  • 5Pro forma financial information is also provided for the quarterly period ended December 29, 2018.
  • 6Includes the consent of Ernst & Young LLP, Esterline's independent registered public accounting firm.

Frequently Asked Questions

This filing is an amendment to a previous 8-K and serves to provide the necessary financial statements and exhibits related to TransDigm's acquisition of Esterline. It ensures that investors have access to the relevant historical financial data of Esterline and pro forma combined financial information to assess the impact of the acquisition.

The audited consolidated financial statements of Esterline as of September 28, 2018, and for the year then ended are incorporated by reference from Esterline's Form 10-K filed on November 21, 2018, as Exhibit 99.1 to this Form 8-K/A.

Pro forma financial statements present the company's financial results as if the Esterline acquisition had occurred at an earlier date. This allows investors to better understand the potential combined financial performance and position of TransDigm and Esterline, excluding the impact of the transaction date itself.

No, this filing does not present new operating or financial results for TransDigm as a standalone entity. Its focus is solely on providing the financial information required for the Esterline acquisition, including historical Esterline financials and pro forma combined statements.